Black women are still dying from breast cancer at significantly higher rates than white women — and the gap isn't closing ...

Spread the loveImagine living with a ticking clock, knowing that every day, your body is slowly, irrevocably failing you.

Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') announced that the first patient has been dosed in a Phase III clinical ...

Explore findings from the 2026 Cell and Gene Therapy Report on oncology adoption, emerging specialties, reimbursement and ...

The 7MM Cutaneous Lupus Erythematosus treatment market was valued at approximately USD 970 million in 2025 and is projected to reach approximately USD 4.3 billion by 2036, growing at a CAGR of ...

Ginkgo Bioworks announced that it will provide in-kind access to its autonomous laboratory in Boston to support the National Science Foundation?s X-Labs program. NSF X-Labs is a $1.5 billion, ...

Open a VIP account (an enterprise account with priority handling, 24/7 dedicated customer care, unlimited usage/users, help on formatting, standards, rules, regulations, policy compliance, etc., and ...

John Fairbanks was diagnosed with AL-Amyloidsis, new treatment retrains cells to fight the disease.

NSCLC development advances after FDA Breakthrough Therapy Designation for previously treated EGFR wild-type, c-Met disease.

On October 6, 2026 (US time), four startups in the United States announced major funding rounds in succession. These include Vinci ($250 million), which handles physical simulations for semiconductors ...

Potentially accelerates development, assessment, and review for approval by FDA Sepsis impacts about 1.7 million U.S. adults ...

The 2026 Nobel Prize in Physiology or Medicine has been jointly awarded to three scientists — Karl Deisseroth, Peter Hegemann and Georg Nagel — for their ...